Search

Your search keyword '"Iredell J"' showing total 256 results

Search Constraints

Start Over You searched for: Author "Iredell J" Remove constraint Author: "Iredell J"
256 results on '"Iredell J"'

Search Results

4. Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19

5. Blood transcriptome responses in patients correlate with severity of COVID-19 disease

7. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020

8. Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial

9. IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study.

12. IFI27 transcription is an early predictor for COVID-19 outcomes; a multi-cohort observational study

13. Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce.

15. Whole genome analysis of ExPEC ST73 from a single hospital over a 2-year period identified different circulating clonal groups

16. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019

17. Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study.

18. Whole-genome analysis of extraintestinal Escherichia coli sequence type 73 from a single hospital over a 2 year period identified different circulating clonal groups

23. Diversity of P1 phage-like elements in multidrug resistant Escherichia coli

26. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance

27. Recommendations for the control of carbapenemase-producing Enterobacteriaceae (CPE): A guide for acute care health facilities: Australian Commission on Safety and Quality in Health Care

28. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

29. Serum lactate cut-offs as a risk stratification tool for in-hospital adverse outcomes in emergency department patients screened for suspected sepsis

30. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance.

31. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial

32. Communication Ambassadors-an Australian Social Media Initiative to Develop Communication Skills in Early Career Scientists

33. Review article: Sepsis in the emergency department - Part 2: Investigations and monitoring

34. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

35. Assessing the public acceptability of proposed policy interventions to reduce the misuse of antibiotics in Australia: A report on two community juries

37. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee

39. Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker Groups

41. Use of an innovative personality-mindset profiling tool to guide culture-change strategies among different healthcare worker groups.

42. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): Study protocol for a randomised controlled trial.

43. What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore.

44. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

45. Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker Groups

46. Applying the emergency risk management process to tackle the crisis of antibiotic resistance

47. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study

49. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia

50. Predictors and outcome associated with an Enterococcus positive isolate during intensive care unit admission.

Catalog

Books, media, physical & digital resources